Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Feb
11
2016
 Remicade Biosimilar Closer To Approval, But Patent Dance Goes On Foley & Lardner LLP
Feb
10
2016
 Positive FDA Advisory Committee Vote for First Monoclonal Antibody Biosimilar – But Will Patent Dispute Delay Launch? Mintz
Feb
10
2016
 Drug Shortages are Forcing Treatments to be Rationed Stark & Stark
Feb
10
2016
 FDA Unveils Action Plan to Combat Opioid Abuse
Feb
10
2016
 First Monoclonal Antibody Biosimilar in U.S. Gets One Step Closer to FDA Approval Mintz
Feb
10
2016
 PTAB Institutes Trial On Previously Challenged Cabilly Patent
Feb
10
2016
 Deciphering Final AMP Rule – Key Provisions Impacting Pharmacies, PBMs, and Manufacturers Mintz
Feb
10
2016
 FDA Food Funding for FY 2017 Keller and Heckman LLP
Feb
10
2016
 USDA Declares “Do-Over” on Overhaul of Biotechnology Regulations Beveridge & Diamond PC
Feb
9
2016
 FDA Issues Draft Guidance on ‘Emerging Signals’ Morgan, Lewis & Bockius LLP
Feb
9
2016
 Cheese Controls re: FDA Safety Criteria Keller and Heckman LLP
Feb
8
2016
 California Court Curbs Chipotle GMO Case Keller and Heckman LLP
Feb
5
2016
 China Food Law: Year in Review 2015 Part II Keller and Heckman LLP
Feb
5
2016
 Sounds Fishy: New Seafood Traceability Program Keller and Heckman LLP
Feb
5
2016
 Coalition for Affordable Drugs V LLC v. Biogen International GmbH - Denying Rehearing of Decision Not to Institute Based on Lack of Showing of Abuse of Discretion IPR2015-01086 Faegre Drinker
Feb
5
2016
 Behind the Curtain: Shkreli was NOT the Big Story on the Hill Today Mintz
Feb
4
2016
 FDA Places Ban on Import of GE Salmon Mintz
Feb
4
2016
 Food Safety: Consumer’s Point of View Keller and Heckman LLP
Feb
4
2016
 Asset Transferee Cannot Appeal Reexamination Foley & Lardner LLP
Feb
3
2016
 No More Genetically Engineered Salmon—In 2016, At Least Morgan, Lewis & Bockius LLP
Feb
3
2016
 Food Imports: Risky Business? Keller and Heckman LLP
Feb
3
2016
 FDA Issues New Draft Guidance on Postmarket Cybersecurity for Medical Devices Morgan, Lewis & Bockius LLP
Feb
2
2016
 FDA Recommends Medical Device Manufacturers Implement a Comprehensive Cybersecurity Risk Management Program in Accordance with NIST Standards Epstein Becker & Green, P.C.
Feb
2
2016
 Federal Circuit Holds Defective Restriction Requirement Ends Patent Term Adjustment Sterne, Kessler, Goldstein & Fox P.L.L.C.
Feb
2
2016
 “Natural” Seal Appeal - Food Labeling Keller and Heckman LLP
Feb
2
2016
 Purdue OxyContin Patents Invalid Despite Stemming From Discovery Of Source Of Toxic Impurity Foley & Lardner LLP
Feb
2
2016
 CMS Final Covered Outpatient Drug Rule Addresses Many Industry Concerns Morgan, Lewis & Bockius LLP
Feb
1
2016
 FDA Releases Draft Guidance for Medical Device Cybersecurity Mintz
Displaying 9829 - 9856 of 12256
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters